|
Zeeshan Feroz describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo HEMATOLOGIC AND HEPATIC TOXICITIES FOLLOWING MULTIPLE DRUG ADMINISTRATION Results of the study suggest that animals of group received amiodarone-glibenclamide-captopril-oxcarbazepine combination revealed comparatively more toxic effects than two other combinations. However, more studies on large number of animals and human beings are required to justify the use of multiple drug administration, since trial in man is the only way of establishing drug interactions. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Department of Pharmacology, University of Karachi, Karachi, Pakistan  Authors' Report Crónica del Autor Bibliographic references Referencias bibliográficas 1. Feroz Z, Khan R, Afroz S. Adverse Effects of Anti-Epileptic, Anti-Hypertensive, Anti-Diabetic and Anti-Arrhythmic Drugs on Hematological and Hepatic Parameters. Lat Am J Pharm 30(2):229-236, 2011. 2. Herlong. Approach to the patient with abnormal liver enzymes. Hosp Pract 29(11):32-38, 1994. 3. Koh Y, Moideen FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 1(1):39-48, 2005. 4. McMillan R. Hemorrhagic disorders: Abnormalities of platelet and vascular function. En: L. Goldman & D. Ausiello (Ed.), W. B. Saunders Company, Philadelphia. pp. 1289-1301, 2007. 5. Mendez M, Parera V, Salamanca RED, Batlle A. Amiodarone is a pharmacologically safe drug for porphyrias. Gen Pharmacol 32(2):259-263, 1999. 6. Pratt DS, MM Kaplan. Evaluation of abnormal liver-enzyme results in asymptomatic patients. New Eng J Med 342(17):1266-1271, 2000. 7. Renner EL, Dallenbach A. Increased liver enzymes: what should be done? Ther Umsch 49(5):281-286, 1992. 8. Richer M, Robert S. Fatal hepatotoxicity following oral administration of amiodarone. Ann Pharmacother 29(6):582-586, 1995. 9. Schafer AI. Thrombocytosis. New Eng J Med 350:1211-1219, 2004. 10. Usdin YS, Sausville EA, Hutchins JB, Thomas K, Woosley RL. Amiodarone-induced lymphocyte toxicity and mitochondrial function. J Cardiovasc Pharm 28(1):94-100, 1996. 11. Weinberger I, Rotenberg Z, Fuchs J, Ben-Sasson E, Agmon J. Amiodarone induced thrombocytopenia. Arch Intern Med 147(4):735-736, 1987. Other articles written by the author Zeeshan Feroz Otros artículos de Zeeshan Feroz 1. Cumulative toxicities on lipid Profile and glucose following administration of anti-epileptic, anti-hypertensive, anti-diabetic and anti-arrhythmic drugs. Pak. J. Pharm. Sci. Vol. 24 (1), Jan (2011) 47-51. 2. Adverse effects of cumulative administration of anti-epileptic, anti-hypertensive, anti-diabetic and anti-arrhythmic drugs on renal and cardiac parameters. Int. J Med. Res. 1 (1), Aug (2010) 39-47. 3. Evaluation of hypoglycemic effect of Cassia italica. J. basic appl. Sci. 7 (1), Jan (2011) 61-64. 4. Effect of Berberis aristata on lipid profile and coagulation parameters. Afr. J. Pharm. Pharmacol. 5 (7), July (2011) 943-947. 5. Effect of multiple drug administration on gross toxicities and electrolytes. Pak. J. Pharmacol. 26 (2), July (2009) 33-39. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Adverse Effects of Anti-Epileptic, Anti-Hypertensive, Anti-Diabetic and Anti-Arrhythmic Drugs on Hematological and Hepatic Parameters Author / Autor Rafeeq Alam Khan1 1 Professor, College Of Medicine; Department Of Basic Medical Sciences; King Saud Bin Abdulaziz University Of Health Sciences; King Abdulaziz Medical City Jeddah Kingdom Of Saudi Arabia, Professor Access to the original source Latin American Journal of Pharmacy siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
|||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
